Cord Blood vs Cord Tissue Banking: What Does AlphaCord Offer?

If you're an expecting parent researching cord blood and cord tissue banking, you've probably run into a wall of medical terminology and conflicting advice. Should you bank cord blood, cord tissue, or both? Is there a meaningful difference? And what exactly does AlphaCord offer when it comes to preserving your newborn's stem cells?

This guide breaks it all down — plainly, honestly, and without the sales pressure. By the end, you'll know exactly what each type of banking involves, what the science says, and how AlphaCord's approach makes the whole process straightforward for American families.

What Is Cord Blood Banking — and Why Does It Matter?

When your baby is born, the umbilical cord contains blood rich in haematopoietic stem cells (HSCs) — the building blocks of the blood and immune system. Cord blood banking is the process of collecting, processing, and cryogenically storing these cells immediately after birth, before the cord is cut and discarded.

💡 Cord blood stem cells are currently used in the treatment of more than 80 diseases, including leukaemia, lymphoma, sickle cell disease, and certain immune disorders. Over 40,000 cord blood transplants have been performed worldwide to date.

HSCs from cord blood have a proven track record in regenerative medicine. They are used in haematopoietic stem cell transplants (also called bone marrow transplants), where they can rebuild a patient's blood and immune system after chemotherapy or radiation. For families with a history of blood cancers or immune conditions, cord blood banking can represent a meaningful biological safety net.

A 2017 review in Bone Marrow Transplantation confirmed that cord blood units remain viable and functional after extended cryogenic storage, supporting the case for long-term banking as a practical option for families.

AlphaCord stores cord blood in a 5-chamber storage bag, which means a single collection yields up to five separate treatment-ready units — giving your family more potential access points over the years, rather than a single-use sample.

What Is Cord Tissue Banking — and How Is It Different?

Cord tissue banking preserves the Wharton's jelly — the gelatinous substance that surrounds the blood vessels inside the umbilical cord. This tissue is rich in mesenchymal stem cells (MSCs), a completely different class of stem cell from those found in cord blood.

Where haematopoietic stem cells (from cord blood) primarily rebuild blood and immune systems, mesenchymal stem cells have a different profile entirely:

• They can differentiate into bone, cartilage, and fat cells

• They have anti-inflammatory and immunomodulatory properties

• They are being actively studied in clinical trials for conditions including cerebral palsy, autism spectrum disorder, multiple sclerosis, Crohn's disease, and osteoarthritis

MSCs are not yet used in established clinical treatments in the same way cord blood HSCs are — but the research pipeline is substantial and accelerating. A 2021 study in Stem Cells Translational Medicine highlighted the therapeutic potential of umbilical cord-derived MSCs across a broad range of inflammatory and degenerative conditions, noting their favourable safety profile and immunosuppressive properties.

Banking cord tissue today means preserving access to these cells at their most potent — newborn MSCs are biologically younger and more proliferative than MSCs collected at any later point in life.

Cord Blood vs Cord Tissue: A Side-by-Side Comparison

Here's how the two types of stem cell banking compare across the key dimensions that matter to most families:

The key takeaway: these are two distinct biological resources. Banking one does not give you the other. Cord blood and cord tissue are collected from the same umbilical cord, but they contain entirely different cell populations with different therapeutic applications.

What About Placental Tissue Banking?

AlphaCord also offers placental tissue banking as part of its most comprehensive package — and it's worth understanding what this adds to the picture.

The placenta is a rich source of additional stem cells, including further populations of MSCs and haematopoietic progenitor cells. Placental tissue is typically discarded after birth. Banking it means preserving a biological resource that is uniquely available in that short window immediately after delivery and never again.

Placenta-derived stem cells are being investigated for regenerative and immune applications, and early-stage research is promising — though, like cord tissue, this sits more firmly in the future-potential category than in established clinical use today.

Do You Need Both — or Just One?

This is the question most parents ask, and the honest answer is: it depends on your family's health history, priorities, and budget.

• Banking cord blood alone makes sense if your primary concern is the established therapeutic uses — blood cancers, immune disorders, and bone marrow conditions. Cord blood HSCs have decades of clinical data behind them.
• Banking cord blood and cord tissue together broadens your family's biological safety net to include the rapidly growing MSC research pipeline. For families with no specific known risk factors, this is the most popular choice because it captures both cell types at birth — the only opportunity you'll ever have.
• Banking all three (cord blood, cord tissue, and placenta) gives the most comprehensive preservation. It's the right choice for families who want maximum future optionality, particularly given how quickly MSC-based therapies are progressing through clinical trials.

The important practical reality: collection happens once, at birth. There is no second chance. Choosing a more comprehensive option at the outset is always easier than wishing you had later.

How AlphaCord Makes This Decision Easy

AlphaCord was founded in 2002 by parents — not executives — who believed that cord blood banking shouldn't be a luxury reserved for high-income families. That founding principle still shapes everything about how AlphaCord operates.

Here's what makes AlphaCord's offering distinct:

• 3-in-1 collection kit. AlphaCord's collection kit is designed to capture cord blood, cord tissue, and placental tissue simultaneously — from a single collection event right after birth. Your delivery team handles it. There's no second procedure, no additional appointments, no disruption to your birth plan.
• Temperature-protected, electronically tracked transport. Once collected, the kit is shipped to AlphaCord's processing facility with temperature monitoring throughout. The chain of custody — from delivery room to cryogenic storage — is verified and documented.
• 5-chamber cord blood storage bag. Rather than storing cord blood as a single unit, AlphaCord uses a 5-chamber bag that divides the sample into five separate compartments. This means up to five potential treatment events from one collection — a meaningful advantage over single-unit storage.
• AABB and AATB accreditation. AlphaCord holds accreditation from both the AABB (the leading international accreditation body for cord blood banking) and the American Association of Tissue Banks. Both require rigorous standards for processing, storage, and quality management. AlphaCord is also FDA registered.
• Engraftment guarantee. AlphaCord backs its storage with an engraftment guarantee of up to $85,000 in the event that stored cells fail to engraft when needed for treatment. This is a meaningful financial commitment — and a signal of confidence in the quality of processing and storage.
• Flexible, transparent pricing. AlphaCord offers annual storage plans or 20-year prepaid options, across three package tiers:

  • Cord Blood only: from $81/month

  • Cord Blood + Cord Tissue: from $116/month

  • Cord Blood + Cord Tissue + Placenta: from $142/month

For families comparing options across US cord blood banks, AlphaCord consistently positions as one of the most accessible without cutting corners on accreditation or storage quality.

Frequently Asked Questions

Does banking cord tissue affect cord blood banking — or vice versa? No. Both are collected from the same umbilical cord, but they are separate samples. The cord blood is drained from the cord vessels, while cord tissue is a segment of the cord itself. Collecting one does not interfere with the other. AlphaCord's 3-in-1 kit handles both simultaneously.

Can cord tissue stem cells be used for my child's sibling or parents? Mesenchymal stem cells from cord tissue are less restricted by HLA matching than cord blood HSCs, making them potentially suitable for use by other family members. However, clinical eligibility always depends on the specific treatment and medical context. Your healthcare provider would assess this at the time of need.

How long can cord blood and cord tissue be stored? Current evidence supports the viability of cryogenically stored samples for at least 25 years, and likely significantly longer. A 2017 study in Bone Marrow Transplantation confirmed the functional integrity of long-term stored cord blood units. AlphaCord offers both annual and 20-year prepaid storage plans.

Ready to Protect Your Family's Future? Start Today.

Cord blood and cord tissue banking represent two different — and complementary — biological resources. Both are collected once, at birth. Both offer therapeutic potential that is either clinically established today or rapidly developing for tomorrow. AlphaCord's 3-in-1 kit and transparent, affordable pricing make it straightforward to preserve both, without choosing between quality and cost.

→ Order Now